Financhill
Back

Mirati Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and MRTX is experiencing slight selling pressure.

Mirati Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 52.26 Buy
20-day SMA: 47.24 Buy
50-day SMA: 54.31 Sell
200-day SMA: 64.16 Sell
8-day EMA: 51.83 Buy
20-day EMA: 49.6 Buy
50-day EMA: 52.81 Sell
200-day EMA: 70.42 Sell

Mirati Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1 Buy
Relative Strength Index (14 RSI): 56.35 Buy
Chaikin Money Flow: -15628 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.65 - 51.29) Buy
Bollinger Bands (100): (46.33 - 77.45) Sell

Mirati Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Mirati Therapeutics Stock

Is Mirati Therapeutics Stock a Buy?

MRTX Technical Analysis vs Fundamental Analysis

Buy
53
Mirati Therapeutics (MRTX) is a Buy

Is Mirati Therapeutics a Buy or a Sell?

Mirati Therapeutics Stock Info

Market Cap:
3.03B
Price in USD:
52.57
Share Volume:
1.01M

Mirati Therapeutics 52-Week Range

52-Week High:
124.81
52-Week Low:
32.96
Buy
53
Mirati Therapeutics (MRTX) is a Buy

Mirati Therapeutics Share Price Forecast

Is Mirati Therapeutics Stock a Buy?

  • Mirati Therapeutics share price is 52.57 while MRTX 8-day exponential moving average is 51.83, which is a Buy signal.
  • The stock price of MRTX is 52.57 while Mirati Therapeutics 20-day EMA is 49.60, which makes it a Buy.
  • Mirati Therapeutics 50-day exponential moving average is 52.81 while MRTX share price is 52.57, making it a Sell technically.
  • MRTX stock price is 52.57 and Mirati Therapeutics 200-day simple moving average is 70.42, creating a Sell signal.

Fundamental Analysis of Mirati Therapeutics

Is Mirati Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.

Technical Analysis of Mirati Therapeutics

Should I short Mirati Therapeutics stock?

* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.